Role of Helicobacter pylori infection in autoimmune systemic rheumatic diseases

World Journal of Gastroenterology

Volumn 20, Issue 36, 2014, Pages 12839-12846

  Radić, Mislav ^a  

^a UNIVERSITY OF SPLIT   (Croatia)

Author keywords

Helicobacter pylori; Pathogenesis; Rheumatoid arthritis; Sj gren's syndrome; Systemic lupus erythematosus; Systemic sclerosis

Indexed keywords

SUPERANTIGEN;

ANTIBODY PRODUCTION; AUTOIMMUNE DISEASE; EFFECTOR CELL; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; LEUKOCYTE ACTIVATION; MICROCHIMERISM; MOLECULAR MIMICRY; NONHUMAN; REVIEW; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; SJOEGREN SYNDROME; STOMACH MUCOSA; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; ANIMAL; AUTOIMMUNITY; COMPLICATION; HELICOBACTER INFECTIONS; HOST PATHOGEN INTERACTION; IMMUNOLOGY; MICROBIOLOGY; PROGNOSIS; RHEUMATIC DISEASES; RISK FACTOR;

ANIMALS; AUTOIMMUNITY; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HOST-PATHOGEN INTERACTIONS; HUMANS; PROGNOSIS; RHEUMATIC DISEASES; RISK FACTORS;

EID: 84928391893     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v20.i36.12839     Document Type: Review

References (54)

1. Amital H, Govoni M, Maya R, Meroni PL, Ori B, Shoenfeld Y, Tincani A, Trotta F, Sarzi-Puttini P, Atzeni F. Role of infectious agents in systemic rheumatic diseases. Clin Exp Rheumatol 2008; 26: S27-S32 [PMID: 18570751]
2. Cover TL, Blaser MJ. Helicobacter pylori in health and disease. Gastroenterology 2009; 136: 1863-1873 [PMID: 19457415 DOI: 10.1053/j.gastro.2009.01.073]
3. Lehours P, Yilmaz O. Epidemiology of Helicobacter pylori infection. Helicobacter 2007; 12 Suppl 1: 1-3 [PMID: 17727452 DOI: 10.1111/j.1523-5378.2007.00541.x]
4. Jung JH, Choi KD, Han S, Jung HY, Do MY, Chang HS, Choe JW, Lee GH, Song HJ, Kim do H, Choi KS, Lee JH, Ahn JY, Kim MY, Bae SE, Kim JH. Seroconversion rates of Helicobacter pylori infection in Korean adults. Helicobacter 2013; 18: 299-308 [PMID: 23521610 DOI: 10.1111/hel.12043]
5. Malfertheiner P, Megraud F, O'Morain CA, Atherton J, Axon AT, Bazzoli F, Gensini GF, Gisbert JP, Graham DY, Rokkas T, El-Omar EM, Kuipers EJ. Management of Helicobacter pylori infection - the Maastricht IV/ Florence Consensus Report. Gut 2012; 61: 646-664 [PMID: 22491499]
6. Graham DY. History of Helicobacter pylori, duodenal ulcer, gastric ulcer and gastric cancer. World J Gastroenterol 2014; 20: 5191-5204 [PMID: 24833849 DOI: 10.3748/wjg.v20.i18.5191]
7. Calvet X, Ramírez Lázaro MJ, Lehours P, Mégraud F. Diagnosis and epidemiology of Helicobacter pylori infection. Helicobacter 2013; 18 Suppl 1: 5-11 [PMID: 24011238 DOI: 10.1111/hel.12071]
8. Miendje Deyi VY, Van den Borre C, Fontaine V. Comparative evaluation of 3 selective media for primary isolation of Helicobacter pylori from gastric biopsies under routine conditions. Diagn Microbiol Infect Dis 2010; 68: 474-476 [PMID: 20926220 DOI: 10.1016/j.diagmicrobio.2010.08.009]
9. Marshall BJ, Warren JR. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1984; 1: 1311-1315 [PMID: 6145023 DOI: 10.1016/S0140-6736(84)91816-6]
10. Sheu BS, Yang HB, Yeh YC, Wu JJ. Helicobacter pylori colonization of the human gastric epithelium: a bug's first step is a novel target for us. J Gastroenterol Hepatol 2010; 25: 26-32 [PMID: 20136973 DOI: 10.1111/j.1440-1746.2009.06141.x]
11. Faria C, Zakout R, Araújo M. Helicobacter pylori and autoimmune diseases. Biomed Pharmacother 2013; 67: 347-349 [PMID: 23583190 DOI: 10.1016/j.biopha.2011.09.015]
12. Palli D, Masala G, Del Giudice G, Plebani M, Basso D, Berti D, Numans ME, Ceroti M, Peeters PH, Bueno de Mesquita HB, Buchner FL, Clavel-Chapelon F, Boutron-Ruault MC, Krogh V, Saieva C, Vineis P, Panico S, Tumino R, Nyrén O, Simán H, Berglund G, Hallmans G, Sanchez MJ, Larrãnaga N, Barricarte A, Navarro C, Quiros JR, Key T, Allen N, Bingham S, Khaw KT, Boeing H, Weikert C, Linseisen J, Nagel G, Overvad K, Thomsen RW, Tjonneland A, Olsen A, Trichoupoulou A, Trichopoulos D, Arvaniti A, Pera G, Kaaks R, Jenab M, Ferrari P, Nesi G, Carneiro F, Riboli E, Gonzalez CA. CagA+ Helicobacter pylori infection and gastric cancer risk in the EPIC-EURGAST study. Int J Cancer 2007; 120: 859-867 [PMID: 17131317 DOI: 10.1002/ijc.22435]
13. Costa AC, Figueiredo C, Touati E. Pathogenesis of Helicobacter pylori infection. Helicobacter 2009; 14 Suppl 1: 15-20 [PMID: 19712163 DOI: 10.1111/j.1523-5378.2009.00702.x]
14. Raghwan R. Host cell contact induces fur-dependent expression of virulence factors CagA and VacA in Helicobacter pylori. Helicobacter 2014; 19: 17-25 [PMID: 24020886 DOI: 10.1111/hel.12087]
15. Chan AO, Chu KM, Huang C, Lam KF, Leung SY, Sun YW, Ko S, Xia HH, Cho CH, Hui WM, Lam SK, Rashid A. Association between Helicobacter pylori infection and interleukin 1beta polymorphism predispose to CpG island methylation in gastric cancer. Gut 2007; 56: 595-597 [PMID: 17369391 DOI: 10.1136/gut.2006.113258]
16. García-González MA, Lanas A, Quintero E, Nicolás D, Parra-Blanco A, Strunk M, Benito R, Angel Simón M, Santolaria S, Sopeña F, Piazuelo E, Jiménez P, Pascual C, Mas E, Irún P, Espinel J, Campo R, Manzano M, Geijo F, Pellisé M, González-Huix F, Nieto M, Espinós J, Titó L, Bujanda L, Zaballa M. Gastric cancer susceptibility is not linked to pro-and anti-inflammatory cytokine gene polymorphisms in whites: a Nationwide Multicenter Study in Spain. Am J Gastroenterol 2007; 102: 1878-1892 [PMID: 17640324]
17. Obonyo M, Sabet M, Cole SP, Ebmeyer J, Uematsu S, Akira S, Guiney DG. Deficiencies of myeloid differentiation factor 88, Toll-like receptor 2 (TLR2), or TLR4 produce specific defects in macrophage cytokine secretion induced by Helicobacter pylori. Infect Immun 2007; 75: 2408-2414 [PMID: 17353291 DOI: 10.1128/IAI.01794-06]
18. Blaser MJ, Atherton JC. Helicobacter pylori persistence: biology and disease. J Clin Invest 2004; 113: 321-333 [PMID: 14755326 DOI: 10.1172/JCI20925]
19. Neumann WL, Coss E, Rugge M, Genta RM. Autoimmune atrophic gastritis - pathogenesis, pathology and management. Nat Rev Gastroenterol Hepatol 2013; 10: 529-541 [PMID: 23774773 DOI: 10.1038/nrgastro.2013.101]
20. Randone SB, Guiducci S, Cerinic MM. Systemic sclerosis and infections. Autoimmun Rev 2008; 8: 36-40 [PMID: 18706530 DOI: 10.1016/j.autrev.2008.07.022]
21. Rak JM, Pagni PP, Tiev K, Allanore Y, Farge D, Harlé JR, Launay D, Hachulla E, Didelot R, Cabane J, Kahan A, Martin M, Granel B, Roudier J, Lambert NC. Male microchimerism and HLA compatibility in French women with sclerodema: a different profile in limited and diffuse subset. Rheumatology (Oxford) 2009; 48: 363-366 [PMID: 19208687]
22. Gilliam AC. Scleroderma. Curr Dir Autoimmun 2008; 10: 258-279 [PMID: 18460891]
23. Faé KC, Diefenbach da Silva D, Bilate AM, Tanaka AC, Pomerantzeff PM, Kiss MH, Silva CA, Cunha-Neto E, Kalil J, Guilherme L. PDIA3, HSPA5 and vimentin, proteins identified by 2-DE in the valvular tissue, are the target antigens of peripheral and heart infiltrating T cells from chronic rheumatic heart disease patients. J Autoimmun 2008; 31: 136-141 [PMID: 18541406 DOI: 10.1016/j.jaut.2008.04.023]
24. Blum A, Tamir S, Mualem K, Ben-Shushan RS, Keinan-Boker L, Paritsky M. Endothelial dysfunction is reversible in Helicobacter pylori-positive subjects. Am J Med 2011; 124: 1171-1174 [PMID: 22114831 DOI: 10.1016/j.amjmed.2011.08.015]
25. Gasbarrini A, Massari I, Serricchio M, Tondi P, De Luca A, Franceschi F, Ojetti V, Dal Lago A, Flore R, Santoliquido A, Gasbarrini G, Pola P. Helicobacter pylori eradication ameliorates primary Raynaud's phenomenon. Dig Dis Sci 1998; 43: 1641-1645 [PMID: 9724144 DOI: 10.1023/A:1018842527111]
26. Csiki Z, Gál I, Sebesi J, Szegedi G. [Raynaud syndrome and eradication of Helicobacter pylori]. Orv Hetil 2000; 141: 2827-2829 [PMID: 11202119]
27. Aragona P, Magazzù G, Macchia G, Bartolone S, Di Pasquale G, Vitali C, Ferreri G. Presence of antibodies against Helicobacter pylori and its heat-shock protein 60 in the serum of patients with Sjögren's syndrome. J Rheumatol 1999; 26: 1306-1311 [PMID: 10381048]
28. Savarino V, Sulli A, Zentilin P, Raffaella Mele M, Cutolo M. No evidence of an association between Helicobacter pylori infection and Raynaud phenomenon. Scand J Gastroenterol 2000; 35: 1251-1254 [PMID: 11199362 DOI: 10.1080/003655200453575]
29. Sulli A, Seriolo B, Savarino V, Cutolo M. Lack of correlation between gastric Helicobacter pylori infection and primary or secondary Raynaud's phenomenon in patients with systemic sclerosis. J Rheumatol 2000; 27: 1820-1821 [PMID: 10914880]
30. Hervé F, Cailleux N, Benhamou Y, Ducrotté P, Lemeland JF, Denis P, Marie I, Lévesque H. [Helicobacter pylori prevalence in Raynaud's disease]. Rev Med Interne 2006; 27: 736-741 [PMID: 16978744 DOI: 10.1016/j.revmed.2006.07.003]
31. Danese S, Zoli A, Cremonini F, Gasbarrini A. High prevalence of Helicobacter pylori type I virulent strains in patients with systemic sclerosis. J Rheumatol 2000; 27: 1568-1569 [PMID: 10852299]
32. Kalabay L, Fekete B, Czirják L, Horváth L, Daha MR, Veres A, Fónyad G, Horváth A, Viczián A, Singh M, Hoffer I, Füst G, Romics L, Prohászka Z. Helicobacter pylori infection in connective tissue disorders is associated with high levels of antibodies to mycobacterial hsp65 but not to human hsp60. Helicobacter 2002; 7: 250-256 [PMID: 12165033 DOI: 10.1046/j.1523-5378.2002.00092.x]
33. Radić M, Martinović Kaliterna D, Bonacin D, Morović Vergles J, Radić J. Correlation between Helicobacter pylori infection and systemic sclerosis activity. Rheumatology (Oxford) 2010; 49: 1784-1785 [PMID: 20498013 DOI: 10.1093/rheumatology/keq137]
34. Radić M, Kaliterna DM, Bonacin D, Vergles JM, Radić J, Fabijanić D, Kovačić V. Is Helicobacter pylori infection a risk factor for disease severity in systemic sclerosis? Rheumatol Int 2013; 33: 2943-2948 [PMID: 23224499 DOI: 10.1007/s00296-012-2585-z]
35. Showji Y, Nozawa R, Sato K, Suzuki H. Seroprevalence of Helicobacter pylori infection in patients with connective tissue diseases. Microbiol Immunol 1996; 40: 499-503 [PMID: 8865155 DOI: 10.1111/j.1348-0421.1996.tb01100.x]
36. El Miedany YM, Baddour M, Ahmed I, Fahmy H. Sjogren' s syndrome: concomitant H. pylori infection and possible correlation with clinical parameters. Joint Bone Spine 2005; 72: 135-141 [PMID: 15797493 DOI: 10.1016/j.jbspin.2004.04.005]
37. Theander E, Nilsson I, Manthorpe R, Jacobsson LT, Wadström T. Seroprevalence of Helicobacter pylori in primary Sjögren's syndrome. Clin Exp Rheumatol 2001; 19: 633-638 [PMID: 11791633]
38. Sorrentino D, Faller G, DeVita S, Avellini C, Labombarda A, Ferraccioli G, Kahlow-Toussaint S. Helicobacter pylori associated antigastric autoantibodies: role in Sjögren's syndrome gastritis. Helicobacter 2004; 9: 46-53 [PMID: 15156903 DOI: 10.1111/j.1083-4389.2004.00197.x]
39. Yamanishi S, Iizumi T, Watanabe E, Shimizu M, Kamiya S, Nagata K, Kumagai Y, Fukunaga Y, Takahashi H. Implications for induction of autoimmunity via activation of B-1 cells by Helicobacter pylori urease. Infect Immun 2006; 74: 248-256 [PMID: 16368978 DOI: 10.1128/IAI.74.1.248-256.2006]
40. Sawalha AH, Schmid WR, Binder SR, Bacino DK, Harley JB. Association between systemic lupus erythematosus and Helicobacter pylori seronegativity. J Rheumatol 2004; 31: 1546-1550 [PMID: 15290733]
41. Scott DL, Wolfe F, Huizinga TW. Rheumatoid arthritis. Lancet 2010; 376: 1094-1108 [PMID: 20870100 DOI: 10.1016/S0140-6736(10)60826-4]
42. Tanaka E, Singh G, Saito A, Syouji A, Yamada T, Urano W, Nakajima A, Taniguchi A, Tomatsu T, Hara M, Saito T, Kamatani N, Yamanaka H. Prevalence of Helicobacter pylori infection and risk of upper gastrointestinal ulcer in patients with rheumatoid arthritis in Japan. Mod Rheumatol 2005; 15: 340-345 [PMID: 17029090 DOI: 10.3109/s10165-005-0419-5]
43. Meron MK, Amital H, Shepshelovich D, Barzilai O, Ram M, Anaya JM, Gerli R, Nicola B, Shoenfeld Y. Infectious aspects and the etiopathogenesis of rheumatoid arthritis. Clin Rev Allergy Immunol 2010; 38: 287-291 [PMID: 19575154 DOI: 10.1007/s12016-009-8158-6]
44. Ishikawa N, Fuchigami T, Matsumoto T, Kobayashi H, Sakai Y, Tabata H, Takubo N, Yamamoto S, Nakanishi M, Tomioka K, Fujishima M. Helicobacter pylori infection in rheumatoid arthritis: effect of drugs on prevalence and correlation with gastroduodenal lesions. Rheumatology (Oxford) 2002; 41: 72-77 [PMID: 11792883 DOI: 10.1093/rheumatology/41.1.72]
45. Zentilin P, Seriolo B, Dulbecco P, Caratto E, Iiritano E, Fasciolo D, Bilardi C, Mansi C, Testa E, Savarino V. Eradication of Helicobacter pylori may reduce disease severity in rheumatoid arthritis. Aliment Pharmacol Ther 2002; 16: 1291-1299 [PMID: 12144579 DOI: 10.1046/j.1365-2036.2002.01284.x]
46. Seriolo B, Cutolo M, Zentilin P, Savarino V. Helicobacter pylori infection in rheumatoid arthritis. J Rheumatol 2001; 28: 1195-1196 [PMID: 11361212]
47. Matsukawa Y, Asai Y, Kitamura N, Sawada S, Kurosaka H. Exacerbation of rheumatoid arthritis following Helicobacter pylori eradication: disruption of established oral tolerance against heat shock protein? Med Hypotheses 2005; 64: 41-43 [PMID: 15533608 DOI: 10.1016/j.mehy.2004.06.021]
48. Mora GF. Systemic sclerosis: environmental factors. J Rheumatol 2009; 36: 2383-2396 [PMID: 19797508 DOI: 10.3899/jrheum.090207]
49. Iwai H, Nakamichi N, Nakae K, Konishi M, Inaba M, Hoshino S, Baba S, Amakawa R. Parotid mucosa-associated lymphoid tissue lymphoma regression after Helicobacter pylori eradication. Laryngoscope 2009; 119: 1491-1494 [PMID: 19504556 DOI: 10.1002/lary.20258]
50. Harris PR, Smythies LE, Smith PD, Dubois A. Inflammatory cytokine mRNA expression during early and persistent Helicobacter pylori infection in nonhuman primates. J Infect Dis 2000; 181: 783-786 [PMID: 10669377 DOI: 10.1086/315257]
51. Wotherspoon AC, Ortiz-Hidalgo C, Falzon MR, Isaacson PG. Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma. Lancet 1991; 338: 1175-1176 [PMID: 1682595 DOI: 10.1016/0140-6736(91)92035-Z]
52. Jackson L, Britton J, Lewis SA, McKeever TM, Atherton J, Fullerton D, Fogarty AW. A population-based epidemiologic study of Helicobacter pylori infection and its association with systemic inflammation. Helicobacter 2009; 14: 108-113 [PMID: 19751435 DOI: 10.1111/j.1523-5378.2009.00711.x]
53. Orrù V, Steri M, Sole G, Sidore C, Virdis F, Dei M, Lai S, Zoledziewska M, Busonero F, Mulas A, Floris M, Mentzen WI, Urru SA, Olla S, Marongiu M, Piras MG, Lobina M, Maschio A, Pitzalis M, Urru MF, Marcelli M, Cusano R, Deidda F, Serra V, Oppo M, Pilu R, Reinier F, Berutti R, Pireddu L, Zara I, Porcu E, Kwong A, Brennan C, Tarrier B, Lyons R, Kang HM, Uzzau S, Atzeni R, Valentini M, Firinu D, Leoni L, Rotta G, Naitza S, Angius A, Congia M, Whalen MB, Jones CM, Schlessinger D, Abecasis GR, Fiorillo E, Sanna S, Cucca F. Genetic variants regulating immune cell levels in health and disease. Cell 2013; 155: 242-256 [PMID: 24074872 DOI: 10.1016/j.cell.2013.08.041]
54. Al-Sammak F, Kalinski T, Weinert S, Link A, Wex T, Malfertheiner P. Gastric epithelial expression of IL-12 cytokine family in Helicobacter pylori infection in human: is it head or tail of the coin? PLoS One 2013; 8: e75192 [PMID: 24069393 DOI: 10.1371/journal.pone.0075192]